Relx Plc (NYSE:RELX – Get Free Report) shares reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $49.58 and last traded at $49.47, with a volume of 682654 shares changing hands. The stock had previously closed at $49.12.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on RELX shares. Redburn Atlantic began coverage on shares of Relx in a research note on Wednesday, January 8th. They issued a “buy” rating for the company. StockNews.com assumed coverage on shares of Relx in a research report on Wednesday, October 30th. They issued a “hold” rating for the company.
View Our Latest Research Report on Relx
Relx Stock Up 2.2 %
Institutional Investors Weigh In On Relx
Institutional investors have recently modified their holdings of the stock. CENTRAL TRUST Co grew its stake in Relx by 1,290.2% in the fourth quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock worth $26,000 after purchasing an additional 529 shares in the last quarter. Versant Capital Management Inc acquired a new position in shares of Relx in the 4th quarter worth approximately $31,000. Private Trust Co. NA increased its holdings in shares of Relx by 119.9% in the 3rd quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock valued at $49,000 after acquiring an additional 566 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of Relx in the 3rd quarter valued at approximately $125,000. Finally, Grove Bank & Trust raised its position in shares of Relx by 10.2% during the 3rd quarter. Grove Bank & Trust now owns 3,758 shares of the technology company’s stock valued at $178,000 after acquiring an additional 348 shares in the last quarter. Institutional investors and hedge funds own 15.02% of the company’s stock.
Relx Company Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Read More
- Five stocks we like better than Relx
- Using the MarketBeat Stock Split Calculator
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Find and Profitably Trade Stocks at 52-Week Lows
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What Does Downgrade Mean in Investing?
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.